J. Sirot

5.5k citations

129 papers · 4.4k indexed · h-index 39

Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 77
Endocrinology top 0.1%
- Enterobacteriaceae and Cronobacter Research 14
- Vibrio bacteria research studies 11
Applied Microbiology and Biotechnology top 0.5%
Pollution top 1%
Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy 35
Molecular Biology
- Bacterial biofilms and quorum sensing 18
Surgery
- Orthopedic Infections and Treatments 15
- Infectious Diseases and Tuberculosis 12
Epidemiology
- Pneumonia and Respiratory Infections 14

Co-authors: D. Sirot Roger Labia C. Chanal Christophe de Champs Richard Bonnet R Cluzel Christiane Forestier B Joly
Cited by: Molecular Medicine Endocrinology Applied Microbiology and Biotechnology
Journals: Antimicrobial Agents and Chemotherapy (29 papers)Journal of Antimicrobial Chemotherapy (12 papers)Journal of Clinical Microbiology (7 papers)
Partner nations: France Denmark United States

In The Last Decade

J. Sirot

121 papers receiving 4.1k citations

Peers

Countries citing papers authored by J. Sirot

Since Specialization

Citations

This map shows the geographic impact of J. Sirot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Sirot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Sirot more than expected).

Fields of papers citing papers by J. Sirot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Sirot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Sirot. The network helps show where J. Sirot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. Sirot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Sirot Line = papers co-authored together J. Sirot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients Critical Care ·Christiane Forestier,D. Guélon,Ahmed S. Hatem,Thierry Gillart,J. Sirot,Christophe de Champs	2008	116
2	TEM-109 (CMT-5), a Natural Complex Mutant of TEM-1 β-Lactamase Combining the Amino Acid Substitutions of TEM-6 and TEM-33 (IRT-5) Antimicrobial Agents and Chemotherapy ·Frédéric Robin,Julien Delmas,C. Chanal,D. Sirot,J. Sirot,Richard Bonnet	2005	26
3	Utilisation de la gélose VCA3 (bioMérieux) pour l'isolement sélectif des Enterococci résistants à la vancomycine à partir de prélèvements fécaux Pathologie Biologie ·Julien Delmas,Frédéric Robin,澄男福井,شويکار سلامة,O. Lesens,J. Sirot,Richard Bonnet	2005	1
4	Frequency and diversity of Class A extended-spectrum β-lactamases in hospitals of the Auvergne, France: a 2 year prospective study Journal of Antimicrobial Chemotherapy ·Christophe de Champs,C. Chanal,D. Sirot,شويکار سلامة,牧野歩実,Richard Bonnet,Nils Grote,L. C. Carosio,Dominicus Makukula,Angie Yineth Díaz Díaz,Timothy Andrew Mitchell,Aleksandra Snoch,MinKyung Ahn JongWoo Kim,Edhy Puerwandono,J. Sirot	2004	53
5	Susceptibility of Enterobacteriaceae to β-lactam agents and fluoroquinolones: a 3-year survey in France Clinical Microbiology and Infection ·J. Sirot,Marie-Hélène Nicolas-Chanoine,H. Chardón,J Avril,C. Cattoën,Unam Unam,H. Dabernat,T. Fosse,Jeff A Wilson,Agung Surya Sanjaya,Shumaila Beg,M. Roussel‐Delvallez,C J Soussy,Pang Yankun,François Vandenesch,Hazem Y. Abd Elazim,Melike Semerci,Yvonne Rezvani	2002	25
6	Les infections à Escherichia coli producteurs de vérotoxines: étude de la prévalence chez l'enfant dans la région Auvergne Archives de Pédiatrie ·Nathalie Pradel,Christophe de Champs,B. Cravames,J. Sirot,Christiane Forestier,B Joly,Flemming Scheutz,V. Livrelli	2000	7
7	Clinical relevance of Proteus mirabilis in hospital patients: a two year survey Journal of Antimicrobial Chemotherapy ·Christophe de Champs,Richard Bonnet,D. Sirot,C. Chanal,J. Sirot	2000	57
8	Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients Journal of Hospital Infection ·Bertrand Souweine,Ousmane Traoré,Bruno Aublet‐Cuvelier,Laurent Bret,J. Sirot,H. Laveran,P. Deteix	2000	32
9	Dialysis and central venous catheter infections in critically ill patients: Results of a prospective study Critical Care Medicine ·Bertrand Souweine,Ousmane Traoré,Bruno Aublet‐Cuvelier,並河守,Laurent Bret,J. Sirot,N Gazuy,H. Laveran,P. Deteix	1999	42
10	Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria Clinical Microbiology and Infection ·J. Sirot,Patrice Courvalin,Claude–James Soussy	1996	21
11	Polyarticular Septic Arthritis Medicine ·Jean‐Jacques Dubost,SEDA ILTER,D. Bancovsky,J-R. Barrau,Martin Soubrier,Jean-Michel Ristori,Alixe Lambart,J. Sirot,B Sauvezie	1993	135
12	Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit Intensive Care Medicine ·Luke Pratsides,D. Guélon,R. Garnier,MinKyung Ahn JongWoo Kim,O. Mansoor,Rodríguez Albizures,J. Sirot	1993	14
13	A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase Journal of Hospital Infection ·Christophe de Champs,G. Shyam,D. Guélon,J. Sirot,D. Sirot,D. Beytout,武文卿	1991	64
14	Klebsiella pneumoniae and Other Enterobacteriaceae Producing Novel Plasmid-Mediated -Lactamases Markedly Active Against Third-Generation Cephalosporins: Epidemiologic Studies Clinical Infectious Diseases ·J. Sirot,C. Chanal,A Petit,D. Sirot,Roger Labia,G Gerbaud	1988	144
15	Interactions of New Plasmid-Mediated -Lactamases with Third-Generation Cephalosporins Clinical Infectious Diseases ·Roger Labia,A Morand,Kiran Tiwari,J. Sirot,D. Sirot,A Petit	1988	48
16	Kinetic properties of two plasmid-mediated β-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins Journal of Antimicrobial Chemotherapy ·Roger Labia,A Morand,Kiran Tiwari,B. Dorney,D. Sirot,J. Sirot	1988	25
17	Pharmacokinetics of cefotaxime and its desacetyl metabolite in plasma and in cerebrospinal fluid European Journal of Drug Metabolism and Pharmacokinetics ·Eric Beyssac,J Cardot,S.HABIB Mostafa,J. Sirot,Jean-Marc Aiache	1987	4
18	Tolérance de la pefloxacine au cours du traitement d'une série d'infections ostéo-articulaires. Trente six cas. Therapies ·J-R. Barrau,Naijela Janaina Costa Silveira,J. Sirot,Álvaro Chapado Gutiérrez,Espen André Wold	1985	1
19	Technique de dosage du céfotaxime et du desacétyl-céfotaxime dans le sérum par chromatographie liquide haute performance. Michael Boyer,J. Sirot,R Cluzel,Ron	1984	1
20	The role of Neisseria mucosa in pyo genie meningitis of children. Ann. Inst. Pasteur ·J. Sirot,M Cluzel	1972	2

About J. Sirot

J. Sirot is a scholar working on Molecular Medicine, Endocrinology and Applied Microbiology and Biotechnology, having authored 129 papers that have together received 4.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (77 papers), Antibiotics Pharmacokinetics and Efficacy (35 papers), Bacterial biofilms and quorum sensing (18 papers), Orthopedic Infections and Treatments (15 papers), Enterobacteriaceae and Cronobacter Research (14 papers), Pneumonia and Respiratory Infections (14 papers), Infectious Diseases and Tuberculosis (12 papers) and Vibrio bacteria research studies (11 papers). The work is most often cited by research in Molecular Medicine (3.1k citations), Endocrinology (1.6k citations) and Applied Microbiology and Biotechnology (396 citations). J. Sirot has collaborated with scholars based in France, Denmark and United States. Frequent co-authors include D. Sirot, Roger Labia, C. Chanal, Christophe de Champs, Richard Bonnet, R Cluzel, Christiane Forestier, B Joly, A Petit and A Morand. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Journal of Clinical Microbiology, Clinical Microbiology and Infection and Journal of Hospital Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact